Fig. 3From: Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-plateletsCell viability of MHCC97H (A) and HepG2 (B) after incubation with different concentrations of HMSNs and PLTM-HMSNs for 24 h. (C) The liver and kidney function indexes of BALB/c mice. All results are presented as the mean ± SD. (D) HE-stained organs from tumor-free BALB/c mice after injected with nanoparticles. Scale bar, 20 μmBack to article page